A Phase 1b, Randomized, Double-Blind, Placebo Controlled, Single-Dose Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GS-5806 in Subjects < 24 Months of Age [...] (2014-2015)

Professor Peter Sly

NHMRC Leadership Fellow

Child Health Research Centre

Faculty of Health, Medicine and Behavioural Sciences